Development of A Nanostructured Lipid Carrier-Based Drug Delivery Strategy for Apigenin: Experimental Design Based on CCD-RSM and Evaluation against NSCLC In Vitro
Non-small-cell lung cancer (NSCLC) is the main cause of cancer-related deaths worldwide, with a low five-year survival rate, posing a serious threat to human health. In recent years, the delivery of antitumor drugs using a nanostructured lipid carrier (NLC) has become a subject of research. This stu...
Main Authors: | Xiaoxue Wang, Jinli Liu, Yufei Ma, Xinyu Cui, Cong Chen, Guowei Zhu, Yue Sun, Lei Tong |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/28/18/6668 |
Similar Items
-
Hyaluronic Acid Modified Nanostructured Lipid Carrier for Targeting Delivery of Kaempferol to NSCLC: Preparation, Optimization, Characterization, and Performance Evaluation In Vitro
by: Yufei Ma, et al.
Published: (2022-07-01) -
Dually Active Apigenin-Loaded Nanostructured Lipid Carriers for Cancer Treatment
by: Bonilla-Vidal L, et al.
Published: (2023-11-01) -
Chemotherapeutic effects of Apigenin in breast cancer: Preclinical evidence and molecular mechanisms; enhanced bioavailability by nanoparticles
by: Moein Adel, et al.
Published: (2022-06-01) -
Synergism Antiproliferative Effects of Apigenin and Naringenin in NSCLC Cells
by: Xiongxiong Liu, et al.
Published: (2023-06-01) -
Alimentación Saludable: ¡Cambie su desayuno!
by: Emily Minton
Published: (2012-05-01)